Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5894

1.

Fogarty International Center collaborative networks in infectious disease modeling: Lessons learnt in research and capacity building.

Nelson MI, Lloyd-Smith JO, Simonsen L, Rambaut A, Holmes EC, Chowell G, Miller MA, Spiro DJ, Grenfell B, Viboud C.

Epidemics. 2018 Oct 23. pii: S1755-4365(18)30029-X. doi: 10.1016/j.epidem.2018.10.004. [Epub ahead of print] Review.

PMID:
30446431
2.

Perspectives towards antiviral drug discovery against Ebola virus.

Mirza MU, Vanmeert M, Ali A, Iman K, Froeyen M, Idrees M.

J Med Virol. 2018 Nov 15. doi: 10.1002/jmv.25357. [Epub ahead of print] Review.

PMID:
30431654
3.

Aeromedical Transfer of Patients with Viral Hemorrhagic Fever.

Nicol ED, Mepham S, Naylor J, Mollan I, Adam M, d'Arcy J, Gillen P, Vincent E, Mollan B, Mulvaney D, Green A, Jacobs M.

Emerg Infect Dis. 2019 Jan 17;25(1). doi: 10.3201/eid2501.180662. [Epub ahead of print]

4.

Avoiding bites and scratches? Understanding the public health implication of human-bat interactions in Ghana.

Lawson ET, Ayivor JS, Ohemeng F, Ntiamoa-Baidu Y.

Zoonoses Public Health. 2018 Nov 14. doi: 10.1111/zph.12540. [Epub ahead of print]

PMID:
30430752
5.

Research and Global Health Emergencies: On the Essential Role of Best Practice.

Sethi N.

Public Health Ethics. 2018 Jul 24;11(3):237-250. doi: 10.1093/phe/phy014. eCollection 2018 Nov.

PMID:
30429871
6.

Tetherin inhibits Nipah virus but not Ebola virus replication in fruit bat cells.

Hoffmann M, Nehlmeier I, Brinkmann C, Krähling V, Behner L, Moldenhauer AS, Krüger N, Nehls J, Schindler M, Hoenen T, Maisner A, Becker S, Pöhlmann S.

J Virol. 2018 Nov 14. pii: JVI.01821-18. doi: 10.1128/JVI.01821-18. [Epub ahead of print]

PMID:
30429347
7.

Congolese fight against Ebola.

Shepherd A.

BMJ. 2018 Nov 14;363:k4814. doi: 10.1136/bmj.k4814. No abstract available.

PMID:
30429137
8.

In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model.

Patel A, Park DH, Davis CW, Smith TRF, Leung A, Tierney K, Bryan A, Davidson E, Yu X, Racine T, Reed C, Gorman ME, Wise MC, Elliott STC, Esquivel R, Yan J, Chen J, Muthumani K, Doranz BJ, Saphire EO, Crowe JE, Broderick KE, Kobinger GP, He S, Qiu X, Kobasa D, Humeau L, Sardesai NY, Ahmed R, Weiner DB.

Cell Rep. 2018 Nov 13;25(7):1982-1993.e4. doi: 10.1016/j.celrep.2018.10.062.

PMID:
30428362
9.

A bioassay-based protocol for chemical neutralization of human faecal wastes treated by physico-chemical disinfection processes: A case study on benzalkonium chloride.

Sozzi E, Baloch M, Strasser J, Fisher MB, Leifels M, Camacho J, Mishal N, Elmes SF, Allen G, Gadai G, Valenti L, Sobsey MD.

Int J Hyg Environ Health. 2018 Nov 10. pii: S1438-4639(17)30733-2. doi: 10.1016/j.ijheh.2018.07.002. [Epub ahead of print]

PMID:
30424942
10.

Vaccine (Vaccination).

Justiz Vaillant AA, Grella MJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 31.

11.

Neutralizing Antibody Titer Test of Ebola Recombinant Protein Vaccine and Gene Vector Vaccine pVR-GP-FC.

Yang R, Zhu Y, Ma J, Hao YZ, Wang X, Hou ML, Liu LP, Fan LY, Cao YX, Zhang XG, Li XJ.

Biomed Environ Sci. 2018 Oct;31(10):721-728. doi: 10.3967/bes2018.097.

12.

Bayesian phylodynamic inference with complex models.

Volz EM, Siveroni I.

PLoS Comput Biol. 2018 Nov 13;14(11):e1006546. doi: 10.1371/journal.pcbi.1006546. [Epub ahead of print]

13.

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

Huttner A, Siegrist CA.

Expert Rev Vaccines. 2018 Nov 13:1-6. doi: 10.1080/14760584.2018.1546582. [Epub ahead of print]

PMID:
30422031
14.

Ebola: Impact of hospital's admission policy in an overwhelmed scenario.

Zahid MH, Kribs CM.

Math Biosci Eng. 2018 Dec 1;15(6):1387-1399. doi: 10.3934/mbe.2018063.

15.

Epidemics and Peptide Vaccine Response - A Brief Review.

Nandy A, Dey S, Roy P, Basak SC.

Curr Top Med Chem. 2018 Nov 12. doi: 10.2174/1568026618666181112144745. [Epub ahead of print]

PMID:
30417788
16.

Admissions and surgery as indicators of hospital functions in Sierra Leone during the west-African Ebola outbreak.

Bolkan HA, van Duinen A, Samai M, Bash-Taqi DA, Gassama I, Waalewijn B, Wibe A, von Schreeb J.

BMC Health Serv Res. 2018 Nov 9;18(1):846. doi: 10.1186/s12913-018-3666-9.

17.

Identifying potential uses of crowdsourcing in global health, conflict, and humanitarian settings: an adapted CHNRI (Child Health and Nutrition Initiative) exercise.

Wazny K, Chan KY; Crowdsourcing CHNRI Collaborators.

J Glob Health. 2018 Dec;8(2):020704. doi: 10.7189/jogh.08.020704.

18.

Development of Competencies for Respiratory Protection for Health Care Workers.

Rogers B, Buckheit K, Ostendorf J.

Workplace Health Saf. 2018 Nov 9:2165079918798857. doi: 10.1177/2165079918798857. [Epub ahead of print]

PMID:
30409086
19.

Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.

Selaković Ž, Tran JP, Kota KP, Lazić M, Retterer C, Besh R, Panchal RG, Soloveva V, Sean VA, Jay WB, Pavić A, Verbić T, Vasiljević B, Kuehl K, Duplantier AJ, Bavari S, Mudhasani R, Šolaja BA.

Eur J Med Chem. 2018 Oct 31;162:32-50. doi: 10.1016/j.ejmech.2018.10.061. [Epub ahead of print]

PMID:
30408747
20.

Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers.

Penny CJ, Vassileva K, Jha A, Yuan Y, Chee X, Yates E, Mazzon M, Kilpatrick BS, Muallem S, Marsh M, Rahman T, Patel S.

Biochim Biophys Acta Mol Cell Res. 2018 Nov 5. pii: S0167-4889(18)30499-3. doi: 10.1016/j.bbamcr.2018.10.022. [Epub ahead of print]

PMID:
30408544

Supplemental Content

Loading ...
Support Center